久日新材: 天津久日新材料股份有限公司关于使用部分募集资金向控股孙公司提供借款以实施募投项目的公告

Core Viewpoint - The company has approved the use of part of its raised funds, amounting to 50 million RMB, to provide a loan to its subsidiary, Hunan Hongrun Chemical Technology Co., Ltd., for the implementation of a project to produce 8,000 tons/year of photoinitiator H4 ketone [1][5]. Fundraising Overview - The company raised a total of 1,854.1574 million RMB through its initial public offering, with a net amount of 1,840.6713 million RMB after deducting issuance costs [1]. - The funds will be allocated to various projects, including the Hunan Hongrun project, which is part of a total investment plan of 2,155.5025 million RMB [2]. Loan Details - The loan to Hunan Hongrun will be provided in installments based on the project's construction schedule and actual funding needs, with a maximum term of 36 months [3][4]. - The interest rate for the loan will be determined based on the latest Loan Prime Rate (LPR) and the company's actual debt financing costs [3][4]. Purpose and Impact of the Loan - The loan aims to ensure the smooth implementation of the fundraising investment project and aligns with the planned use of raised funds, without altering the intended use or harming shareholder interests [5]. - Hunan Hongrun is a stable subsidiary with controllable financial risks, which supports the rationale for the loan [5]. Fund Management Post-Loan - The funds will be managed through a dedicated account at Hunan Hongrun, with a tripartite supervision agreement involving the company, a commercial bank, and the sponsor institution [6]. - The management of the funds will comply with relevant regulations and the company's fundraising management system [6]. Opinions from Supervisory Bodies - The supervisory board agrees that the loan aligns with the needs of the fundraising investment project and does not change the intended use of the funds, thus protecting the interests of the company and its shareholders [6]. - The sponsor institution has no objections to the loan arrangement, confirming compliance with regulatory requirements [6].